×
{"type":"img","src":"//cdn.quv.kr/vzwi0cy6x/up/64390eaccc743_1920.png","height":40}
  • ABOUT US
  • R&D
  • IR
  • PR
  • CONTACT
  • {"google":["Noto Sans"],"custom":["Noto Sans KR"]}
    ×
     
     
    섹션 설정
    {"type":"img","src":"//cdn.quv.kr/vzwi0cy6x/up/5e1adcec2c4de_1920.png","height":"21"}
  • 기업소개
  • 연구개발
  • 투자정보
  • 홍보
  • CONTACT
  • Company Introduction

    MANAGEMENT PHILOSOPHY

    Through R&D from our unique technology and expertise,

    we will try our best in becoming a reliable global-standard biopharmaceuticals company.

    A&T Pharma's time runs backwards.

    Select A&T Pharma now.

    We'll retrieve your beautiful times.

    Company Name

    A&T Pharma corporation

    Date of establishment

    01. January. 2014

    Business Registration Number

    412 - 81 - 49923

    CEO

    Do Young  Jeong

    Headquarters

    801~803 C, 520, Misa-daero, Hanam-si, Gyeonggi-do, Korea

    Phone number

    02 - 6925 - 5538

    CEO’s Message

    Welcome and warm greetings! 

    For your health and beauty

    A&T Pharma will be with you.

    A&T Pharma is a biopharmaceutical company that has officially secured C. Botulinum A str. in 2019 for aesthetic and therapeutic R&D of Botulinum toxin type A products purposes.


    We are not the pioneers of Botulinum toxin type A products, but will become the best product manufacturer through continuous R&D.
    Our passion is dedicated to not only developing the best products for the beauty and wellness of our customers, but also to giving back to the society of which we are a part of. 


    Through these approaches to the world, we will become a one-stop shop to improving lives of all.
    Stay tuned, we sincerely appreciate your interest.


    CEO    Do Young Jeong

     

    Corporate History

    A&T Pharma 2023

    2023 12

    Chuncheon City investment attraction MOU (related to manufacturing facilities)

     2023 01

    Completed Botulinum toxin pre-clinical contract and started

     2021 07

    Expanded  and transferred HQ Office and R&D center

    (Mapo-gu, Seoul  → Hanam-si, Gyeoungi-do)

    2021 06

    Certified venture company(R&D)

    2020 20

    Permission to possess botulinum strains according to law revision

    (Korea Centers for Disease Control and Prevention)

    2019 12

    Approval of Botulinum toxin type A / Clostridium Botulinum A str. manufacturing facility (MOTIE)

    2019 10

    Establishment of Blacktree Inc. Botulinum R&D center

    2019 08

    Transferred company HQ (Sangam-dong, Mapo-gu, Seoul)

    2019 07

    Registration of Clostridium Botulinum A str.  (KCDC, Korea Center for Disease Control)

    Registration of Botulinum toxin type A / Clostridium Botulinum A str. (MOTIE, Ministry of Trade, Industry, and Energy)

    2019 05

    Signed contract for securing Botulinum toxin type A/ Clostridium Botulinum A str.

    Expanded business criteria (biomaterials manufacturing

    2014 01

    Established company

    Organization Chart

    Location

    ADDRESS

    801~803 C, 520, Misa-daero, Hanam-si, Gyeonggi-do, Korea

    PHONE

    02-6925-5538 / +82-2-6925-5538

    E-MAIL

    admin@antpharma.co.kr

    FAX

    02-6925-5539 / +82-2-6925-5539

    {"google":["Noto Sans"],"custom":["Noto Sans KR"]}{"google":["Noto Sans"],"custom":["Noto Sans KR"]}
    {"google":[],"custom":["Noto Sans KR"]}